Cargando…

The Relationship between Higher Chronic Opioid Therapy Dose and Specific Personality Traits in Individuals with Chronic Pain

OBJECTIVE: To evaluate the relationship between opioid use and specific personality traits among individuals with chronic pain stratified by morphine equivalent doses (MEQ). DESIGN: Observational cohort study. Setting. Chronic pain outpatient clinic in Canada (2017–2019). Patients. Participants were...

Descripción completa

Detalles Bibliográficos
Autores principales: McIntyre, Amanda, Mehta, Swati, Vanderlaan, Danielle, Sequeira, Keith, Loh, Eldon, Teasell, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261182/
https://www.ncbi.nlm.nih.gov/pubmed/34257765
http://dx.doi.org/10.1155/2021/9946067
_version_ 1783718961610752000
author McIntyre, Amanda
Mehta, Swati
Vanderlaan, Danielle
Sequeira, Keith
Loh, Eldon
Teasell, Robert
author_facet McIntyre, Amanda
Mehta, Swati
Vanderlaan, Danielle
Sequeira, Keith
Loh, Eldon
Teasell, Robert
author_sort McIntyre, Amanda
collection PubMed
description OBJECTIVE: To evaluate the relationship between opioid use and specific personality traits among individuals with chronic pain stratified by morphine equivalent doses (MEQ). DESIGN: Observational cohort study. Setting. Chronic pain outpatient clinic in Canada (2017–2019). Patients. Participants were included if they (1) were at least 18 years old, (2) had been diagnosed with chronic pain (pain >3 months), and (3) were able to read and write in English. Interventions. None. Main Outcome Measures. Completion of the following outcome measures: Acceptance and Action Questionnaire, Anxiety Sensitivity Index, Brief-Coping with Problems Experience 28-item, Brief Pain Inventory Short Form, CAGE-AID substance misuse screening tool, EuroQol-5D, Generalized Anxiety Disorder 7-item, and Patient Health Questionnaire 9-item. One-way analysis of variance compared outcomes between MEQ groups. RESULTS: 215 individuals (64.2% female) were included with a mean age of 52.7 ± 11.7 years and time since pain onset of 14.1 ± 10.2 years (range 1–45). There were no significant differences between MEQ groups with respect to sociodemographic and clinical health variables except for gender and employment status and time since pain onset. After controlling for gender, time since pain onset, and average pain severity, patients with MEQ 90+ mg had significantly higher scores for experiential avoidance and anxiety sensitivity in addition to increased pain interference, greater depressive and anxiety symptoms, more dysfunctional coping, and poorer QoL than those with MEQ 1–89 mg or MEQ 0 mg. CONCLUSIONS: Compared to individuals using no or lower-dose opioids to treat chronic pain, those using high-dose opioids had higher scores on two maladaptive personality traits (i.e., anxiety sensitivity and experiential avoidance) which was associated with poorer mood, greater pain interference, lower quality of life, and dysfunctional coping. These maladaptive personality traits may help to explain how individuals with chronic pain utilize higher doses of opioid analgesics.
format Online
Article
Text
id pubmed-8261182
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-82611822021-07-12 The Relationship between Higher Chronic Opioid Therapy Dose and Specific Personality Traits in Individuals with Chronic Pain McIntyre, Amanda Mehta, Swati Vanderlaan, Danielle Sequeira, Keith Loh, Eldon Teasell, Robert Pain Res Manag Research Article OBJECTIVE: To evaluate the relationship between opioid use and specific personality traits among individuals with chronic pain stratified by morphine equivalent doses (MEQ). DESIGN: Observational cohort study. Setting. Chronic pain outpatient clinic in Canada (2017–2019). Patients. Participants were included if they (1) were at least 18 years old, (2) had been diagnosed with chronic pain (pain >3 months), and (3) were able to read and write in English. Interventions. None. Main Outcome Measures. Completion of the following outcome measures: Acceptance and Action Questionnaire, Anxiety Sensitivity Index, Brief-Coping with Problems Experience 28-item, Brief Pain Inventory Short Form, CAGE-AID substance misuse screening tool, EuroQol-5D, Generalized Anxiety Disorder 7-item, and Patient Health Questionnaire 9-item. One-way analysis of variance compared outcomes between MEQ groups. RESULTS: 215 individuals (64.2% female) were included with a mean age of 52.7 ± 11.7 years and time since pain onset of 14.1 ± 10.2 years (range 1–45). There were no significant differences between MEQ groups with respect to sociodemographic and clinical health variables except for gender and employment status and time since pain onset. After controlling for gender, time since pain onset, and average pain severity, patients with MEQ 90+ mg had significantly higher scores for experiential avoidance and anxiety sensitivity in addition to increased pain interference, greater depressive and anxiety symptoms, more dysfunctional coping, and poorer QoL than those with MEQ 1–89 mg or MEQ 0 mg. CONCLUSIONS: Compared to individuals using no or lower-dose opioids to treat chronic pain, those using high-dose opioids had higher scores on two maladaptive personality traits (i.e., anxiety sensitivity and experiential avoidance) which was associated with poorer mood, greater pain interference, lower quality of life, and dysfunctional coping. These maladaptive personality traits may help to explain how individuals with chronic pain utilize higher doses of opioid analgesics. Hindawi 2021-06-28 /pmc/articles/PMC8261182/ /pubmed/34257765 http://dx.doi.org/10.1155/2021/9946067 Text en Copyright © 2021 Amanda McIntyre et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
McIntyre, Amanda
Mehta, Swati
Vanderlaan, Danielle
Sequeira, Keith
Loh, Eldon
Teasell, Robert
The Relationship between Higher Chronic Opioid Therapy Dose and Specific Personality Traits in Individuals with Chronic Pain
title The Relationship between Higher Chronic Opioid Therapy Dose and Specific Personality Traits in Individuals with Chronic Pain
title_full The Relationship between Higher Chronic Opioid Therapy Dose and Specific Personality Traits in Individuals with Chronic Pain
title_fullStr The Relationship between Higher Chronic Opioid Therapy Dose and Specific Personality Traits in Individuals with Chronic Pain
title_full_unstemmed The Relationship between Higher Chronic Opioid Therapy Dose and Specific Personality Traits in Individuals with Chronic Pain
title_short The Relationship between Higher Chronic Opioid Therapy Dose and Specific Personality Traits in Individuals with Chronic Pain
title_sort relationship between higher chronic opioid therapy dose and specific personality traits in individuals with chronic pain
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261182/
https://www.ncbi.nlm.nih.gov/pubmed/34257765
http://dx.doi.org/10.1155/2021/9946067
work_keys_str_mv AT mcintyreamanda therelationshipbetweenhigherchronicopioidtherapydoseandspecificpersonalitytraitsinindividualswithchronicpain
AT mehtaswati therelationshipbetweenhigherchronicopioidtherapydoseandspecificpersonalitytraitsinindividualswithchronicpain
AT vanderlaandanielle therelationshipbetweenhigherchronicopioidtherapydoseandspecificpersonalitytraitsinindividualswithchronicpain
AT sequeirakeith therelationshipbetweenhigherchronicopioidtherapydoseandspecificpersonalitytraitsinindividualswithchronicpain
AT loheldon therelationshipbetweenhigherchronicopioidtherapydoseandspecificpersonalitytraitsinindividualswithchronicpain
AT teasellrobert therelationshipbetweenhigherchronicopioidtherapydoseandspecificpersonalitytraitsinindividualswithchronicpain
AT mcintyreamanda relationshipbetweenhigherchronicopioidtherapydoseandspecificpersonalitytraitsinindividualswithchronicpain
AT mehtaswati relationshipbetweenhigherchronicopioidtherapydoseandspecificpersonalitytraitsinindividualswithchronicpain
AT vanderlaandanielle relationshipbetweenhigherchronicopioidtherapydoseandspecificpersonalitytraitsinindividualswithchronicpain
AT sequeirakeith relationshipbetweenhigherchronicopioidtherapydoseandspecificpersonalitytraitsinindividualswithchronicpain
AT loheldon relationshipbetweenhigherchronicopioidtherapydoseandspecificpersonalitytraitsinindividualswithchronicpain
AT teasellrobert relationshipbetweenhigherchronicopioidtherapydoseandspecificpersonalitytraitsinindividualswithchronicpain